Euthanasia of pregnant animals

For euthanasia of pregnant animals, a rapid and painless death is essential. The technique of euthanasia should minimize stress and anxiety experienced by the animal so far as possible. The death is induced by an anoxia in the central nervous system or by a pharmacologic inhibition of essential neuronal functions. Pentobarbital is the best suited drug for euthanasia of animals and especially of pregnant animals. Combinations with muscle relaxing agents should not be used because of possible apnoe without unconsciousness.     

Nitrogen requirement of pregnant gilts

Eleven Yorkshire x Landrace gravid gilts were used in two Latin square trials to determine the N requirement for pregnancy. Semipurified diets were formulated to be adequate in indispensable amino acids (IAA) and other nutrients. Diets were fed once daily (1.82 kg); L-glutamic acid, corn sugar, powdered cellulose, and soybean oil percentages differed to maintain isocaloric diets. In Trial 1, six gilts were fed diets containing 6.6 to 17.2% CP equivalent (19.2 to 50.1 g of N/d) during six 10-d periods beginning on d 40 postcoitum. In Trial 2, five gilts were fed diets containing 4.3 to 12.6% CP equivalent (12.5 to 36.8 g of N/d) during five 10-d periods beginning on d 50 postcoitum. Nitrogen balance trials were conducted during the last 5 d of each period. Blood samples were taken both before and 3 h after the last feeding of each period. Results from Trial 1 suggested that adequate N retention (10 g/d) could be attained by pregnant gilts fed less than 28 g of N/d intake when the diet contained indispensible amino acids at levels suggested by Nutrient Requirements of Swine (NRC, 1988). An intake of 20.6 g of N/d (7.1% CP equivalent) yielded near maximum N retention among pregnant gilts fed the semipurified diets in Trial 2. Other criteria measured (urine urea nitrogen and plasma urea nitrogen) had limited value in the evaluation of the N status of the pregnant gilts in these trials.     

Gastric cannulation of pregnant sows

The purpose of this project was to study the effect of superalimentation in lactating sows through permanent, surgically placed, gastric cannulas. A surgical technique was developed to install gastric cannulas into pregnant sows to allow superalimentation by introducing feed through the cannula. After induction of general anesthesia, a flexible, T-shaped cannula (22 mm outside diameter) was surgically placed in the dorsal portion of the greater curvature of the stomach and exteriorized through the tenth intercostal space approximately 30 cm left of the dorsal midline. Cannulas were installed on day 85 +/- 5 days of gestation. Anesthesia, surgical procedures, and the subsequent presence of the cannula did not affect the size or number of live pigs at birth. In addition, the prevalence of stillbirths and mummified fetuses was not significantly different than that of noncannulated sows. The gastric cannulas did not affect lactation performance, as litter size and weight were unaffected when compared with that in noncannulated controls. Postmortem examination of euthanatized sows revealed adhesions of the gastric wall to the abdominal wall, thus eliminating the possibility of leakage of the gastric contents into the peritoneum. Detrimental effects of the cannulas on gastric function or capacity were not detected, and cannulas could be maintained through multiple parities.     

妊娠母猪的阶段饲喂

母猪的繁殖性能与母猪繁殖周期的各阶段的营养密切相关,某一阶段的营养会影响此阶段、后一阶段乃至全程的生产性能。因此,妊娠母猪也应像生长猪一样采取阶段饲喂。本文主要阐述了妊娠前期、中期和后期母猪饲养管理方面的研究。     

Detomidine in pregnant cows

Evidence that the course of gestation in dairy cattle is not influenced by the administration of detomidine, a novel sedative and analgesic agent.     

孕犬慎用的药物

孕犬如果生病，犬病防治人员在对其进行治疗时，必须有选择性地使用一些药物，以免因使用药物不当对新生胎儿及母犬机体造成损害。本文对孕犬禁用或应慎用的抗生素和中草药进行了整理和归纳，希望引起有关人员的重视。     

Transplacental transfer of propofol in pregnant ewes

Propofol is an injectable anaesthetic that is currently used both in veterinary and human medicine for the induction and maintenance of anaesthesia. Although little is known about the pharmacokinetics of propofol in fetuses, it is widely used in obstetric procedures, particularly in caesarean section. This study determines the pharmacokinetics of propofol in pregnant ewes in the last third of pregnancy, and placental transfer and pharmacokinetics in fetuses after the administration of a 6 mg/kg intravenous (i.v.) bolus (phase 1) or a 6 mg/kg i.v. bolus followed by continued infusion of 0.4 mg/kg/min. In ewes, the area under the blood concentration-time curve (AUC) and C(max) (8.6 mgh/mL and 9.5mg/mL, respectively) was higher than those of the fetus (1.6 mgh/mL and 1.19 mg/mL, respectively). The mean half-life was 0.5h in the dam and 1.1h in the fetus.     

Persistent excretion of rotavirus by pregnant cows

In a study of the epizootiology and prevalence of enteropathogens which may be involved in neonatal calf diarrhoea, 10 in-calf cows from a herd with a history of rotavirus-induced calf diarrhoea were monitored over a period of six to seven months. All the cows excreted rotavirus intermittently without showing any clinical signs, and 21.8 per cent of faecal samples contained rotavirus. Reoviruses were isolated from 87 per cent of the samples from the cows, and from all the 10 calves born to them. However, rotavirus was detected in only one calf, and diarrhoea developed only in this calf even though the calves were housed in communal pens. Campylobacter jejuni was isolated from six of the 10 dams and from five of the 10 calves, not including the calf with diarrhoea. Other potential enteropathogens such as cryptosporidium, salmonella, Clostridium difficile, coronavirus and other viruses were not found, but two cows and two calves shed enterotoxigenic Escherichia coli.     

Energy requirements of pregnant and lactating sows

The energy requirement of pregnant and lactating sows is derived on the basis of extensive experimental studies of the energy metabolism (indirect calorimetry, slaughtering) according to the factorial method. For the first reproduction cycle (RC) 0.41 MJ metabolizable energy (ME) or 0.29 MJ net energy fat, pig (NEFpig) resp. were necessary for energy maintenance requirement for pregnant and lactating sows and, depending on age, 0.44 MJ ME or 0.31 MJNEFpig in the second or third RC and 0.47 MJ ME/kg LW0.75.d or 0.33 MJ NEFpig/kg LW0.75.d in the 4th-8th RC. A linear increase of up to 6% of the energy requirement caused by pregnancy between the 85th and 115th day of pregnancy is taken into consideration. Energy requirement per 1 MJ retention both in pregnancy and lactation is 1.45 MJ ME or 1.03 MJ NEFpig, per 1 MJ milk yield it is 1.33 MJ ME or 0.91 MJ NEFpig. 1 MJ body energy for milk yield corresponds to 1.20 MJ ME or 0.82 MJ NEFpig. Equations describing energy retention in the products of conception, uterus and udder are established as well as equations characterizing the connections between live weight gain or loss and energy content of the gain or loss.     

Vaccination of pregnant ponies against equine rhinopneumonitis

Bovine herpesvirus 1247 (one dose) was given subcutaneously to five pregnant pony mares between 227 and 319 days of their gestations. There were no adverse clinical reactions, and the virus was not recovered from nasal swabs collected during a 2-week period after vaccination. Four ponies foaled full-term, live, healthy foals. The foal of the fifth mare (No. 1) was found dead, but on the basis of the pathologic and virologic examinations, the virus was not considered to be the cause of the death. At 3 weeks after vaccination, the pregnant pony mares had a 13- to 250-fold increase in serum antibody titer to equine herpesvirus-1. A virulent-virus challenge exposure of all pony mares at 208 days after vaccination resulted in antibody titers greater than those just before this exposure. Virus was recovered from nasal swabs from vaccinated mares only on postexposure day 1, whereas the one control (nonvaccinated) pony shed virus for at least 3 days after challenge exposure. The immunogenic and the nonabortifacient characteristics of the herpesvirus 1247 in pregnant pony mares indicate that it may be useful to vaccinate horses against equine herpesvirus-1.